Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

RANK-RANKL signaling is essential for hair growth and skin health.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Finasteride helps reduce heart issues and improves heart function.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Adrenal disorders can cause lasting brain and behavior issues in children.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.